Hope for pancreatic cancer outcomes | Telehealth drones
- ST. LOUIS, MO—Critical research taking place at Washington University could hold promise for pancreatic cancer outcomes. Pancreatic cancer is often detected late, spreads rapidly, and has a poor prognosis because of its resistance to chemotherapy. A group of researchers at the Washington University School of Medicine have identified a drug compound that makes pancreatic cancer cells more vulnerable to chemotherapy.
- ST. LOUIS, MO—In other news from Washington University—You don’t have to be an all-star pitcher to suffer a rotator cuff tear. In fact, this is the most common type of tendon injury in adults. Unfortunately, surgery to repair such injuries have a high failure rate. Researchers at the Genin lab have looked more closely at how tendon and bone attach in the shoulder joint, uncovering engineering strategies for attaching dissimilar materials.
- COLUMBUS, OH—Researchers at The Ohio State University (OSU) Wexner Medical Center, OSU College of Medicine and OSU College of Public Health have developed a self-administered test to identify the early, more subtle signs of dementia sooner when compared to the most commonly used office-based tests. The Self-Administered Gerocognitive Examination (SAGE test) provides doctors with a baseline of their patients’ cognitive functioning.
- CINCINNATI, OH—A team at the University of Cincinnati is building a telehealth drone that will be able to maneuver through a front door and into a patient’s living room carrying a tablet or smart phone. Patients would then connect with a doctor for a telehealth appointment and access a special medical kit attached to the drone so they can measure and transmit health information.